Medication info

Tabaratine Tablet (Pitavastatin Calcium)

Prescription medicationTabletOralExpired
Ingredient · strength
Pitavastatin Calcium›2mg / 1 tablet
Manufacturer / importer
Daewon BioTech Co., Ltd.
Appearance
Very light yellowish-red round film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Expired

MFDS item code 202100458 · Approved 2021.01.18

This product's status changed to Expired on 2026.01.18. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Improvement of primary hypercholesterolemia and mixed dyslipidemia
Who takes it
Adults
Adult dose
Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine. The usual initial dose for adults is 1~2 milligrams of pitavastatin calcium once daily. If the reduction in LDL cholesterol is insufficient, the dose may be increased to a maximum of 4 milligrams daily. Adjust the dose as appropriate at intervals of 4 weeks or longer according to the LDL cholesterol level, treatment goal, and patient response. The therapeutic effect of this medicine is maintained with continued use.

Ingredients

Manufacturer
Daewon BioTech Co., Ltd.

Efficacy & effects

Improvement of primary hypercholesterolemia and mixed dyslipidemia

  • Primary hypercholesterolemia
  • heterozygous familial
  • non-familial
  • mixed dyslipidemia
  • elevated total cholesterol
  • LDL-cholesterol
  • apolipoprotein B
  • triglyceride levels
View approved original text

This medication helps lower total cholesterol, LDL-cholesterol, apolipoprotein B, and triglyceride levels in patients with primary hypercholesterolemia and mixed dyslipidemia. It also contributes to increasing HDL-cholesterol levels, improving cardiovascular health. Used in conjunction with dietary measures, it assists in controlling lipid levels, playing a crucial role in the prevention of cardiovascular diseases. This helps improve blood lipid balance and maintain health.

How to take

Adult dose

Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine. The usual initial dose for adults is 1~2 milligrams of pitavastatin calcium once daily. If the reduction in LDL cholesterol is insufficient, the dose may be increased to a maximum of 4 milligrams daily. Adjust the dose as appropriate at intervals of 4 weeks or longer according to the LDL cholesterol level, treatment goal, and patient response. The therapeutic effect of this medicine is maintained with continued use.

Precautions

This medication should not be used in certain patients. For example, it should not be administered to those allergic to its components, those with severe liver disease, muscle disorders, pregnant or nursing women, and children. Particular caution should be taken when using this medication in patients with liver or kidney dysfunction. Patients with impaired liver function should reduce the dosage, and those with decreased kidney function should stop taking the medication immediately if symptoms such as muscle pain or weakness occur. Additionally, because this medication is primarily metabolized in the liver, individuals with liver impairment must regularly undergo liver function tests. If liver dysfunction is detected, the medication may need to be discontinued. This medication may affect muscles, potentially leading to severe muscle disorders such as muscle pain, muscle weakness, or rhabdomyolysis, so any muscle-related symptoms should be reported immediately. Rarely, allergic reactions such as skin rashes, itching, or hives may occur, so if such symptoms appear, it is necessary to stop the medication and consult a physician. This medication may interact with other drugs, particularly when taken with cyclosporine, fibrate medications, niacin, or erythromycin. Using these medications together may severely impair kidney function. Elderly patients may experience more pronounced side effects, thus requiring careful monitoring and possible dosage adjustments. Pregnant or potentially pregnant women and nursing mothers should not take this medication, as it may be harmful to the fetus. The safety and efficacy of this medication have not been established in children, so it is not used in this population. During treatment, regular blood tests and liver function tests are necessary, and if there is no therapeutic effect, the medication should be discontinued. Finally, this medication should be stored out of reach of children and kept in its original container for safety.

Side effects

  • Abdominal pain
  • rash
  • malaise
  • paralysis
  • itching
  • myalgia
  • weakness
  • elevated CPK levels
  • increased myoglobin in blood and urine
  • acute renal failure
Show 82 more
  • liver dysfunction
  • jaundice
  • thrombocytopenia
  • urticaria
  • erythema
  • angioedema
  • elevated bilirubin
  • increased cholinesterase
  • elevated AST
  • elevated ALT
  • elevated γ-GT
  • elevated ALP
  • elevated LDH
  • rigidity
  • drowsiness
  • insomnia
  • headache
  • heaviness in the head
  • dizziness
  • thirst
  • dyspepsia
  • abdominal distension
  • constipation
  • stomatitis
  • vomiting
  • loss of appetite
  • glossitis
  • nausea
  • discomfort in the stomach
  • diarrhea
  • granulocytopenia
  • leukopenia
  • eosinophilia
  • leukocytosis
  • elevated globulin
  • positive Coombs test
  • anemia
  • polyuria
  • elevated BUN
  • elevated serum creatinine
  • decreased aldosterone
  • increased aldosterone
  • elevated adrenocorticotropic hormone
  • elevated cortisol
  • decreased testosterone
  • muscle cramps
  • fatigue
  • palpitations
  • tiredness
  • skin pain
  • burning sensation
  • arthralgia
  • edema
  • blurred vision
  • photophobia
  • hearing loss
  • hematuria
  • elevated uric acid levels
  • elevated serum potassium and phosphorus
  • taste disturbance
  • malaise
  • positive antinuclear antibodies
  • sleep disturbances
  • memory loss
  • depression
  • interstitial lung disease
  • sexual dysfunction
  • diabetes
  • immune-mediated necrotizing myopathy
  • myasthenia gravis
  • ocular myasthenia
  • facial swelling
  • arm swelling
  • hypersensitivity
  • headache
  • dizziness
  • skin tingling
  • insomnia
  • loss of appetite
  • elevated blood pressure
  • chest discomfort
  • weakness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light and should be stored in a light-protected container. It is important to maintain its efficacy by storing it at room temperature between 1 to 30 degrees Celsius.

Appearance and packaging

Appearance

Very light yellowish-red round film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.